GENERIC DRUGS- DO THEY OFFER THE SAME SAFETY AND EFFICACY AS ORIGINATOR MEDICINES? -PERCEPTIONS AND ATTITUDES OF FINAL YEAR PHARMACY STUDENTS IN GREECE

Author(s)

Gkinou C1, Kani C2, Souliotis K2, Karalis V1, Markantonis S1
1National and Kapodistrian University of Athens, Athens, Greece, 2University of Peloponnese, Corinth, Greece

OBJECTIVES:  In recent years, the generic drug has been the subject of public debate in Greece. The use of generic drugs effectively reduces public pharmaceutical expenditure and improves the sustainability of the social security system. The aim of the present study was to evaluate the knowledge perceptions and attitudes of final year pharmacy students towards generic drugs. METHODS:  Final year pharmacy students of three Universities in Greece were invited to fill out an electronic questionnaire relating to respondents use, perceptions and knowledge of generic drugs. 40 closed-ended, multiple choice and cumulative scoring scale questions were included. Descriptive statistics were used to analyse study findings using the Microsoft Excel program. RESULTS:  173 students (36 male) took part in the survey. Analysis of the resultant data indicated that 89% of the pharmacy students were aware that generic products are comparable in dosage form, strength and route of administration to originator medicines, but may contain different excipients (71%) and may be sold for significantly lower prices (78%). Despite, the generally positive attitude towards generic drugs of >90% of pharmacy students, a significant percentage did not have a clear opinion of their safety (46%) and efficacy (55%) compared to brand-name products. Almost all the students considered it important that (1) the National Organization of Medicine (EOF) be responsible for establishing bioequivalence of generic medicines and (2) health professionals be better educated about generics so as to better educate patients. CONCLUSIONS: The Greek government has already taken several steps toward increasing the use of generics and improving their integration into the local healthcare system. In keeping with the results of the survey, students, patients and health professionals need to be better informed about generics. Greek pharmaceutical industries, the state and health professionals should take measures to sustain the assimilation of generics into the Greek market.

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PHP126

Topic

Economic Evaluation, Health Policy & Regulatory

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Reimbursement & Access Policy

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×